Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

ZALTRAP ZIV-AFLIBERCEPT 阿柏西普

ZALTRAP® Indications
Combined with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI regimen) for the treatment of:
• Adult patients with metastatic colorectal cancer (mCRC) resistant to or progressing on an oxaliplatin-containing regimen
• Disease progression must be confirmed during or within 6 months after completion of oxaliplatin-containing therapy

Share: